Dr. Earle O. Assanah, MD

Dr. Assanah practices at Landmark Medical Center in Woonsocket, Rhode Island, part of Prime Healthcare Services.

Dr. Assanah's NPI, 1063692184, was assigned on November 6, 2007. Dr. Assanah graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 1998. Dr. Assanah holds New York license 223572.

Dr. Assanah's primary practice is Landmark Medical Center, at 115 Cass Avenue, Woonsocket, RI 02895 in Providence County. The practice phone is (401) 769-4100.

Dr. Assanah's primary practice is Landmark Medical Center in Woonsocket, Rhode Island, part of Prime Healthcare Services. Dr. Assanah is also affiliated with Rhode Island Hospital. The medical group on file is Landmark Medical Group. Dmand AI also links Dr. Assanah to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Assanah practices, 3 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Assanah's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Assanah is licensed in New York.

CMS data shows 850 Medicare services from Dr. Assanah across 18 procedure codes in 2024, for 536 Medicare patients. Medicare paid $29,075 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 536 Medicare patients who saw Dr. Assanah in 2024. The largest group is 75 to 84, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Assanah's median patient age at 68, with 54% women.

In 2024, Dr. Assanah wrote 32 Medicare Part D claims for 26 patients. 100% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $121 in total drug cost. In 2023, CMS named 31 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Assanah for performance year 2024, reported as part of a group. Dr. Assanah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Assanah in 2014. 2014 was the busiest year, with 2. Dr. Assanah's most frequent co-authors are Rhian Elizabeth Davies, DO, Seymour Katz, MD and Lauren Audrey Licata, MD.

CMS Open Payments shows 89 general payments to Dr. Assanah from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic USA, Inc. paid the most, $2,782.

Dr. Assanah graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 1998.